ProExC triage of atypical glandular cells on liquid-based cervical cytology specimens

Journal of Lower Genital Tract Disease

Volumn 15, Issue 1, 2011, Pages 6-10

  Fletcher, Andrew Hamilton ^a   Barklow, Thomas A ^a   Murphy, Nina J ^a   Culbertson, Leah H ^a   Davis, Angie V ^a   Hunter, Louise ^a  

^a Watauga Pathology Associates   (United States)

Author keywords

AGC; ASCCP guidelines; atypical glandular cells; ProExC

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING) A; MINICHROMOSOME MAINTENANCE PROTEIN 2; PRESERVATIVE;

ARTICLE; ATYPICAL GLANDULAR CELLS FAVOR NEOPLASIA; ATYPICAL GLANDULAR CELLS NOT OTHERWISE SPECIFIED; BREAST METASTASIS; CANCER DIAGNOSIS; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENDOMETRIUM CARCINOMA; FALSE POSITIVE RESULT; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LIQUID BASED PAPANICOLAOU TEST; PAPANICOLAOU TEST; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; UNITED STATES; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

ADULT; AGED; ANTIGENS, NEOPLASM; BIOPSY; CELL CYCLE PROTEINS; CERVIX UTERI; CYTOLOGICAL TECHNIQUES; DNA TOPOISOMERASES, TYPE II; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NUCLEAR PROTEINS; PRECANCEROUS CONDITIONS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

EID: 78651363414     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/LGT.0b013e3181f0b4b7     Document Type: Article

References (13)

1. Bibbo M, Wilbur DC Comprehensive Cytopathology. 3rd ed. Philadelphia, PA: Saunders and Elsevier; 2008;87.
2. Solomon D, Nayar R. The Bethesda System for Re-porting Cervical Cytology. Definitions, Criteria and Explanatory Notes. 2nd ed. New York, NY: Springer-Verlag; 2004:124.
3. Bibbo M, Wilbur DC Comprehensive Cytopathology. 3rd ed. Philadelphia, PA: Saunders and Elsevier; 2008:227.
4. Wright TC, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 Consensus guidelines for the management of women with abnormal cervical screening tests. J Lower Gen Tract Dis 2007;11:201-22.
5. Lee KR, Darragh TM, Joste NE, Krane JF, Sherman ME, Hurley LB, et al. Atypical glandular cells of undetermined significance (AGUS): interobserver reproducibility in cervical smears and corresponding thin-layer preparations. Am J Clin Pathol 2002;117:96-102.
6. Sanati S, Huettner P, Ylagan LR. Role of ProExC: a novel immunoperoxidase marker in the evaluation of dys-plastic squamous and glandular lesions in cervical specimens. Int J Gynecol Pathol 2010;29:79-87.
7. Tambouret RH, Misdraji J, Wilbur DC Longitudi-nal clinical evaluation of a novel antibody cocktail for detec-tion of high-grade squamous intraepithelial lesions on cervical cytology specimens. Arch Pathol Lab Med 2008;132:918-25.
8. Badr RE, Walts AE, Chung F, Bose S. BD ProExC: a sensitive and specific marker of HPV-associated squamous lesions of the cervix. Am J Surg Pathol 2008;32:899-906.
9. Shroyer KR, Homer P, Heinz D, Singh M. Validation of a novel immunocytochemical assay for topoisomerase II-α and minichromosome maintenance protein-2 expression in cervical cytology. Cancer 2006;108:324-30.
10. Kelly D, Kincaid E, Fansler Z, Rosenthal DL, Clark DP Detection of cervical high-grade squamous intraepithelial lesions from cytologic samples using a novel immunohisto-chemical assay (ProExC). Cancer 2006;108:494-500.
11. ProExC Aberrant S-Phase Induction (for Cytology) [package insert 779-11000-20 Rev. A]. Burlington NC: Tri-Path Imaging Inc; 2006.
12. Menezes GA, Wakely PE, Stripe DM, Nuovo GJ. Increased incidence of atypical Papanicolaou tests from Thinpreps of postmenopausal women receiving hormone re-placement therapy. Cancer 2001;93:357-63.
13. Freeman A, Morris LS, Mills AD, Stoeber K, Laskey RA, Williams GH, et al. Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Canc Res 1999;5:2121-32.